¡¡¡¡CSPC Pharmaceutical Group Limited (hereinwith called CSPC Pharma.) was founded on August 21, 1997 by the strong union of Hebei Pharmaceutical Group company, Shijiazhuang No.1 Pharmaceutical Group Company, and so on, total 4 companies. It is the first one of the oversized pharmaceutical enterprises that were founded by strong union in pharmaceutical industry and a backbone enterprise group of Hebei Province.

¡¡¡¡Currently CSPC’s total asset is above 8 billion Yuan. It has approx. 15,000 staff members and possesses Zhongrun, Weisheng, Zhongnuo, Zhongrun Neimeng, NBP, etc., more than 10 wholly-owned or holding subsidiaries. Among them, the one that was established in Hongkong--China Pharmaceutical Group Co., Ltd (hereinwith called China Pharma.) is the No.1 in China’s pharmaceutical industry that went to the abroad market. It is the biggest pharmaceutical company on Hongkong market at present and is also one of the Constituent Stocks of Hongkong Heng Seng Red Chips index.

¡¡¡¡In 2003 and 2004, two continuous years, China Pharma. was evaluated as one of the global 100 excellent listed companies with turnover below 1 billion US dollar. In 2007, CSPC pharma. achieved sale value of 8 billion RMB, revenue of 0.687 billion RMB, net income of 0.485 billion RMB and direct export of 0.3 billion US dollar which ranked No.1 among China’s pharmaceutical enterprises.

¡¡¡¡CSPC Pharma. is an oversized pharmaceutical enterprise with the integration of science, industry and trade. It is mainly engaged in pharmaceuticals development and research, manufacture and sale. Its products comprise antibiotics, vitamins, cardiovascular, analgesics, digesting system etc. 6 big series and about 1000 kinds. Penicillins and vitamins are its leading products, and it has the annual production capacities of 3,000 tons Vitamin C, 15,000 tons penicillins, 1,600 tons 7-ACA, 5000 tons amoxicillin, and all of them rank No.1 in the world. Its caffein and ranitidine also occupies very important positions on the domestic and foreign markets. Moreover, CSPC Pharma. has strong annual production capacity for preparations, such as powder for injection 3 billion vials, tablet 20 billion, capsules 5 billion, soft capsules 1 billion …It can be said that the output, scale, strength of the leading products of CSPC Pharma. rank top in the whole nation and CSPC Pharma. has been developed to be one of China’s biggest manufacturing bases of chemical raw materials and comprehensive preparations. By now, CSPC Pharma.’s products have been sold in the whole nation and more than 50 countries and regions in the world.
Over the past 10 years since it was founded, CSPC Pharma. has been constantly blazing new trails, making new progresses and have achieved leapfrog development. Early or late, CSPC Pharma. has been awarded the honor titles of “Advanced Collective in domestic medical system” “Advanced Quality and Efficiency Enterprises”, “Good Quality Credit Standing Company”, “Environment Protecting Enterprise” and the diploma of domestic May 1st Labor.
In brand-building, CSPC Pharma.’s trademark ( )has been evaluated as “China’s Well-known trademark” by State Administration of Industry and Commerce. And by one of the five major global brand value assessment agencies---World Brand Evaluation Laboratories’ assessment, in 2008, CSPC brand has been twice selected into the “500 Most Valuable Chinese Brands” and continuously three times been to the top 500 Chinese Enterprises list. In 2007, CSPC Pharma. ranked No.2 among China’s top 100 of pharmaceutical industry.

¡¡¡¡CSPC Pharma. possesses “Post-doctoral Scientific Research Stations”, “National Enterprise Technical Centers” , “Preparation Engineering Technical Center of Hebei Province” and is the “High and New Technological Industrialization Base” as part of China’s “863 Program”. In recent years, CSPC Pharma. has developed more than 90 new medications available nationwide. Currently, there are 8 largest categories of over 70 varieties medications in development and research including the aged use drugs, cardiovascular drugs, antibiotics, anesthetics, antipyretic analgesic drugs, immune-enhancing drugs, children use drugs and genetic engineering drugs, involving in various fields, such as biological technology, hands of synthetic drugs, traditional Chinese medicine injection, liposomes, transdermal preparations, microcapsules agent …By now, CSPC has applied for 89 patents and has obtained approval for 24. Furthermore, 10 patents have been filed under the international Patent Cooperation Treaty (PCT). The national first-class new medicine--Butylphthalide (NBP) whose intellectual property rights are owned by CSPC Pharma., is a world-leading medication for stroke treatment and has been listed as a national “1035 Project” and key task in China’s national 8th Five-Year Plan and 9th Five-Year Plan. It is also the third national first-class new medicine with independent intellectual property rights and has set a precedent that pharmaceutical intellectual property transfers from China to developed countries

¡¡¡¡Looking ahead, CSPC Pharma. stuff will continue to uphold the business philosophy “producing quality medicine on behalf of China”, commit to the cause of human health, with more, newer, better drugs contributing to society. All stuff members will continue to work hard to make CSPC Pharma. the domestic first-class group and one of the world’s top 500 large-scale pharmaceutical enterprises !